Skip to main content
. Author manuscript; available in PMC: 2018 Jun 1.
Published in final edited form as: Med Sci Sports Exerc. 2017 Jun;49(6):1197–1208. doi: 10.1249/MSS.0000000000001224

Table 1.

Pre- to post-training absolute change for MHC fiber-typing and myofiber CSA immunohistochemical analysis1

Change

TRT PB WP PRO MDP PRO vs MDP PRO vs MDP
MHC (relative
frequency)
Mixed Model Linear Contrast Estimates ANCOVA
Estimates
  I −1.6 (−8.3,5.1) 1.3 (−6.9,9.4) −0.2 (−5.3,4.9) −0.5 (−8.1,7.2) 0.2 (−4.3,4.6) 1.8 (−4.0,7.7)
  IIa 7.6 (0.3,14.9) 5.1 (−3.7,14.0) 6.4 (0.8,11.9) 6.9 (−1.4,15.3) −0.3 (−5.2,4.6) −0.3 (−7.9,7.4)
  Hybrid −5.9 (−12.2,0.36) −6.4 (−14.0,1.2) 6.2 (−10.9,−1.4) −6.5 (−13.7,0.55) 0.22 (−4.0,4.4) −0.8 (−7.5,5.9)

CSA, microns2
  I 527 (55,998) 519 (−46,1084) 523 (168,878) 849 (321,1378) −163 (−474,147) −206 (−721,308)
  IIa 963 (409,1518) 941 (278,1606) 952 (536,1369) 936 (315,1558) 8 (−357,373) 125 (−506,755)
  Hybrid 945 (297,1593) 1121 (368,1784) 1033 (554,1513) 1207 (484,1931) −87 (−511,337) 67 (−636,769)
  All 857 (343,1372) 759 (142,1375) 808 (421,1196) 1000 (423,1578) −96 (−435,243) −33 (−617,551)
1

Data are mean ± 95%CI or SEM, n=15 (WP), 22 (PB) & 17 (MDP). Boldface p<0.05, underlined p<0.10 vs pre for that treatment or comparison. MHC, Myosin Heavy Chain. TRT, treatment.